NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Biomakers

Biomakers

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://biomakers.io/

Last Round

Seed Round

Apr 29, 2026

Total Funding Raised

$11M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Biomakers is a biotechnology company that provides a precision medicine and oncology intelligence platform transforming clinical and genomic information into actionable insights for therapeutic and diagnostic development.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Biotechnology, Medical AI, Healthcare Analytics, Clinical Trials

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

precision oncology platformoncology intelligencereal-world datatumor biobankprecision medicineclinical-genomic datasetsdrug development supportreal-world evidenceclinical trial supportgenomic testingmolecular diagnosticsmedical AIdiverse patient datahealthcare analyticsNGS testingbiospecimensData as a Service

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Biomakers Comps

Public and private peers based on sector, stage, and business model.

Biomakers comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Biomakers Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundApr 29, 2026
Series AJan 21, 2026
SAFEDec 16, 2021

Key People

Founding team and executive leadership

Nicolas Kirchuk

CEO & Co-Founder

Founding Team

Biomakers Investors

Notable investors and investment history

Biomakers investors
InvestorRounds
Zentynel Frontier InvestmentsSeries A
Sonen CapitalSeries A
SV Latam CapitalSeries A, SAFE
Sky High VCSeries A
Oncology VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 29, 2026

    Raised $6M in seed funding.

  • Jan 21, 2026

    Raised $8M from Labcorp Venture Fund and others.

Biomakers Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Biomakers Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Biomakers's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range77
Year Founded2014
Last FundingApr 29, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.